A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors

Phase 1 Completed 22 enrolled Medical University of South Carolina

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether oral administration of curcumin causes biological changes in primary tumors of breast cancer patients.

Timeline

Start: 2020-01-29
Primary completion: 2022-03-24
Completion: 2023-03-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Curcumin	Small molecule	500 mg	Oral

A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors

Summary

Timeline

Drugs

Indications